AKT1 and chronic kidney disease: Secondly, patients with CKD are more likely to have diabetes or insulin resistance which may aggravate LV hypertrophy and, subsequently, diastolic and systolic dysfunction through the phosphoinositide-3 kinase–AKT pathway [17,27].